BTG plc (BTG) Rating Reiterated by Stifel Nicolaus
BTG plc (LON:BTG)‘s stock had its “hold” rating reissued by investment analysts at Stifel Nicolaus in a report issued on Thursday. They currently have a GBX 640 ($8.35) price objective on the stock. Stifel Nicolaus’ price objective points to a potential downside of 8.31% from the company’s current price.
Several other analysts also recently commented on the stock. Numis Securities Ltd reissued a “hold” rating and set a GBX 737 ($9.62) price objective on shares of BTG plc in a research report on Thursday. JPMorgan Chase & Co. reissued a “neutral” rating on shares of BTG plc in a research report on Friday, September 9th. Deutsche Bank AG reissued a “buy” rating on shares of BTG plc in a research report on Thursday, September 8th. Finally, Jefferies Group reissued a “buy” rating and set a GBX 860 ($11.23) price objective on shares of BTG plc in a research report on Friday, July 15th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of GBX 799.57 ($10.44).
Shares of BTG plc (LON:BTG) opened at 696.50 on Thursday. The company’s market cap is GBX 2.67 billion. The company’s 50-day moving average is GBX 629.82 and its 200-day moving average is GBX 641.22. BTG plc has a 12-month low of GBX 504.00 and a 12-month high of GBX 739.50.
In other news, insider Soderstrom,Rolf sold 74,327 shares of the firm’s stock in a transaction dated Thursday, July 21st. The shares were sold at an average price of GBX 676 ($8.82), for a total transaction of £502,450.52 ($655,855.01).
BTG plc Company Profile
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.